Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 5,249 shares at $16.95 ($89K) on 2011-04-29, disclosed to the SEC on 2011-05-03.
Scheduled sale ($89k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.95 | 829 | $14K | 15.8% |
| 2 | $16.95 | 1,087 | $18K | 20.7% |
| 3 | $16.95 | 3,333 | $56K | 63.5% |
| Total | $16.95 avg | 5,249 | $89K | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |